The all-virtual 2020 AACE Master Class series provides up to approximately 60 hours of CME and MOC eligible content from leading authorities on:

– Lipids and Cardiovascular Health
– Bone and Parathyroid Disease
– Nutrition and Obesity
– Diabetes
– Thyroid Disease
– Pituitary, Gonad, Adrenal and Neuroendocrine Disease

Whether you are just starting your career or have many years of experience, the AACE Master Class series has something relevant and timely to inspire you. The AACE Master Class series currently features OnDemand, online opportunities such as:

Topics: 

Diabetes

– AACE_ACE Comprehensive Type 2 Diabetes Management Algorithm
– Diabetic Ketoacidosis in Non-Type 1 Diabetes
– How Does One Set Up Diabetes Technology and Survive in the Private Practice Setting-
– Managing Type 2 Diabetes in Younger Populations – Epidemiology and Trends of Type 2 Diabetes Among Youths
– Novel Therapies for Diabetic Kidney Disease
– Personalizing Therapies for the Prevention of Type 1 Diabetes- Searching for Endotypes

Thyroid

– Advanced Thyroid Cancer Frontiers II- TKI Treatment When Do We Start?
– Anaplastic Thyroid Cancer in 2020 – The Emerging Role of Neoadjuvant Therapy and Surgery for BRAF-Mutated Disease
– DSN Year in Review- Thyroid DSN
– Graves Disease in Pregnancy
– Preop Cancer Frontiers I- FNA Mutational Data and Extent of Surgery Decisions
– Preop Cancer Frontiers II- Medullary Thyroid Cancer – Can We Miss It?
– Thyroid and Diet
– Thyroid Autoimmunity in Pregnancy and the Postpartum
– Ultrasound Evaluation and Analysis of Thyroid Nodules
– Ultrasound Evaluation of Diffuse Thyroid Disease and Thyroiditis
– Ultrasound Guided Fine Needle Aspiration

Bone

– 2020 AACE Postmenopausal Osteoporosis Treatment Guidelines
– Atypical Femur Fractures- Site, Type, and Management Considerations
– Bone Fragility in Type I and Type II Diabetes
– Bone Health in Transgender Patients
– Clinical Pearls in Hypercalcemia
– DSN Year in Review – Bone
– FRAX Flaws and Atlernative Fracture Risk Assessment Tools
– Identification and Management Strategies for Vertebral Fractures as part of a larger symposium on Fractures – Site, Type, and Management Considerations
– Long Term Osteoporosis Therapies- Drug Interruption and Monitoring
– Metabolic & Bariatric Surgery- Good for Diabetes, but Bad for the Bones
– Normocalcemic and Normohorhormonal Primary Hyperparathyroidism
– Postsurgical Hypoparathyroidism- Morbidity and Medical Management
– Primary Hyperparathyroidism 2020- The Parathyroid Glands & Cardiovascular Disease
– Revision Parathyroidectomy – Current Guidelines Statements
– Secondary Hyperparathyroidism
– Surgical Treatment – Latest on Parathyroid Auto Fluorescence and ICG Angiography

Lipids and Cardiovascular Health

– Clinical Lipidology for the Endocrinologist
– Clinical Lipidology for the Endocrinologist – Individualizing Lipid Lowering Therapy
– Coronary Artery Calcium Scanning
– Lipids and Cardiovascular Health DSN 2020 Year in Review
– Lipoprotein(a), Cardiovascular Disease, and Calcific Aortic Valve Stenosis
– Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes- Time for Endocrinologists to Take Action
– Rare Lipid Disorders for the Endocrinologist
– AACE_ACE- 2020 Algorithm for the Management of Dyslipidemia and Prevention of Cardiovascular Disease

Nutrition and Obesity

– Can Technology Improve Measurement of Nutrition and Physical Activity-
– DSN Year in Review- Obesity and Nutrition
– Eat Fat to Lose Weight- the Low Carbohydrate, High Fat Diet
– Non-nutritive Sweeteners and Obesity
– Nutrition and Cardiovascular Mortality
– Primary Endoscopic Weight Loss and Metabolic Therapies – Current and Future Technologies

Pituitary, Gonad, Adrenal and Neuroendocrine 

– Adult GHD – New Guidelines and How to Incorporate into Clinical Practice
– Bias in Clinical Reasoning- A Case-Based Discussion with Practical Takeaways
– DSN Year in Review- PGAN
– Evaluation and Management of Adrenal Masses
– Gender-Specific Characteristics in Acromegaly
– Laboratory Testing in Endocrinology- The Highs and the Lows
– Management of Prolactin – and GH – Secreting Adenomas During Pregnancy
– Medical Therapies for Acromegaly in the Era of Precision Medicine
– Non-tumoral Hyperprolactinemia
– Pheochromocytoma and Pseudopheochromocytoma
– Pituitary Stalk Thickening- Differential dx and Management
– Rationale for and Practical Progesterone Therapy for Transwomen
– Should Older Men with Age-Related Decline in Testosterone levels Receive Testosterone Replacement-
– Sodium Perturbations after Pituitary Surgery
– What’s New in the Treatment of Neuroendocrine Tumors-

Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Time for Endocrinologists to Take Action

– Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Time for Endocrinologists to Take Action

Should Older Men with Age-Related Decline in Testosterone levels Receive Testosterone Replacement

– Should Older Men with Age-Related Decline in Testosterone levels Receive Testosterone Replacement

Personalizing Therapies for the Prevention of Type 1 Diabetes Searching for Endotypes

– Personalizing Therapies for the Prevention of Type 1 Diabetes Searching for Endotypes

Clinical Science Late-breaking Presentations

– Diagnostic-Accuracy-of-DHEAS-in-Mild-Autonomous-Cortisol-Secretion

– Glycemic-Control-In-Patients-Achieving-Diabetes-Remission-With-Weight-Loss-By-Bariatric-Surgery

Oral Poster Presentations

– Acceptability and Feasibility of an Innovative, User-Friendly, Interactive Technology-Based Lifestyle Intervention for Weight Loss
– Arterial Stiffness and Hepatic Fibrosis in Nash Have Independently Significant, Bilateral Correlation in Adults with Type 2 Diabetes
– Genetic Predictors of Differences in Continuous Glycemic Curve Parameters in Patients with Type 2 Diabetes Receiving Vildagliptin Therapy
– Impact of Thyroid Hormone Replacement on the Incidence of Heart Failure
– Levoketoconazole in the Treatment of Endogenous Cushing’s Syndrome- Extended Evaluation Phase Results of the Sonics Study
– Risk Stratification for Patients with Papillary Thyroid Microcarcinoma – A Retrospective Cohort Study
– Treatment with Oral Octreotide Capsules May Not Influence Glycemic Control in Patients with Acromegaly- Results from the Phase 3 Chiasma Optimal Study

Date of Release : summer 2020